Total Payments
$2,827
2023 Payments
$262.69
Companies
19
Transactions
64
Medicare Patients
4,953
Medicare Billing
$611,508
Payment Breakdown by Category
Food & Beverage$2,766 (97.9%)
Education$60.07 (2.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,766 | 54 | 97.9% |
| Education | $60.07 | 10 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $438.45 | 12 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $433.86 | 8 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $281.06 | 7 | $0 (2019) |
| Novo Nordisk Inc | $239.38 | 4 | $0 (2023) |
| Amgen Inc. | $198.62 | 3 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $193.85 | 3 | $0 (2019) |
| AbbVie Inc. | $156.30 | 4 | $0 (2023) |
| Amarin Pharma Inc. | $146.43 | 2 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $126.20 | 10 | $0 (2017) |
| Aralez Pharmaceuticals US Inc. | $91.75 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $262.69 | 5 | AbbVie Inc. ($109.44) |
| 2022 | $64.94 | 1 | AstraZeneca Pharmaceuticals LP ($64.94) |
| 2020 | $252.59 | 3 | Janssen Pharmaceuticals, Inc ($106.00) |
| 2019 | $519.15 | 12 | Janssen Pharmaceuticals, Inc ($152.20) |
| 2018 | $789.15 | 16 | Janssen Pharmaceuticals, Inc ($180.25) |
| 2017 | $937.98 | 27 | AstraZeneca Pharmaceuticals LP ($167.66) |
All Payment Transactions
64 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/08/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.83 | General |
| Category: NEUROSCIENCE | ||||||
| 05/16/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $80.00 | General |
| Category: Diabetes Care | ||||||
| 05/16/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $73.25 | General |
| Category: Obesity | ||||||
| 02/01/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $56.64 | General |
| Category: NEUROSCIENCE | ||||||
| 01/27/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: NEUROSCIENCE | ||||||
| 05/05/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $64.94 | General |
| Category: Respiratory | ||||||
| 02/26/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $65.22 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/25/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $106.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/18/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $81.37 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $55.70 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/07/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $72.05 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/08/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Education | In-kind items and services | $14.90 | General |
| Category: RESPIRATORY | ||||||
| 06/03/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Education | In-kind items and services | $5.26 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/15/2019 | Melinta Therapeutics, Inc. | Baxdela (Drug) | Food and Beverage | In-kind items and services | $68.98 | General |
| Category: ANTIBIOTICS | ||||||
| 03/27/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $75.14 | General |
| Category: Hypertriglyceridemia | ||||||
| 03/27/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Education | In-kind items and services | $4.64 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/19/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Education | In-kind items and services | $6.25 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/06/2019 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $66.03 | General |
| Category: Cardiology | ||||||
| 02/25/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Education | In-kind items and services | $6.25 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/07/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $69.85 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/06/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $74.10 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/03/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $63.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/30/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Education | In-kind items and services | $6.25 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/27/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $102.18 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/07/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $72.48 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,041 | 2,434 | $269,530 | $144,419 |
| 2022 | 14 | 1,256 | 2,798 | $303,195 | $154,561 |
| 2021 | 15 | 1,303 | 2,814 | $315,770 | $164,154 |
| 2020 | 16 | 1,353 | 2,884 | $315,405 | $148,375 |
Total Patients
4,953
Total Services
10,930
Medicare Billing
$611,508
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 363 | 1,188 | $118,800 | $63,753 | 53.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 142 | 329 | $49,350 | $28,597 | 57.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 120 | 430 | $43,000 | $25,326 | 58.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 103 | 133 | $33,250 | $13,181 | 39.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 81 | 107 | $11,770 | $6,558 | 55.7% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 78 | 78 | $3,105 | $2,603 | 83.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 78 | 78 | $1,950 | $1,911 | 98.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 28 | 31 | $4,340 | $1,177 | 27.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 16 | 17 | $1,190 | $681.76 | 57.3% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 13 | 20 | $2,200 | $556.38 | 25.3% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 19 | 23 | $575.00 | $73.83 | 12.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 384 | 1,191 | $119,100 | $61,391 | 51.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 169 | 397 | $59,550 | $32,462 | 54.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 123 | 523 | $52,300 | $28,715 | 54.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 89 | 125 | $31,250 | $12,903 | 41.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 83 | 122 | $13,420 | $6,650 | 49.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 137 | 137 | $3,425 | $3,357 | 98.0% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2022 | 138 | 138 | $3,450 | $2,770 | 80.3% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 22 | 23 | $5,750 | $2,351 | 40.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 28 | 34 | $4,760 | $1,277 | 26.8% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2022 | 20 | 35 | $3,850 | $918.34 | 23.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 20 | 22 | $1,540 | $783.91 | 50.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $2,400 | $512.54 | 21.4% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 14 | 19 | $1,900 | $405.07 | 21.3% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 17 | 20 | $500.00 | $64.63 | 12.9% |
About Dr. Suresh Thomas, MD
Dr. Suresh Thomas, MD is a Internal Medicine healthcare provider based in Beckley, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700967122.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Suresh Thomas, MD has received a total of $2,827 in payments from pharmaceutical and medical device companies, with $262.69 received in 2023. These payments were reported across 64 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($2,766).
As a Medicare-enrolled provider, Thomas has provided services to 4,953 Medicare beneficiaries, totaling 10,930 services with total Medicare billing of $611,508. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Beckley, WV
- Active Since 10/19/2006
- Last Updated 09/14/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1700967122
Products in Payments
- XARELTO (Drug) $433.19
- JARDIANCE (Drug) $260.51
- FARXIGA (Drug) $222.67
- Repatha (Biological) $198.62
- ENTRESTO (Drug) $193.85
- Vascepa (Drug) $146.43
- SOLIQUA (Drug) $119.15
- UBRELVY (Drug) $106.34
- ZONTIVITY (Drug) $91.75
- Ozempic (Drug) $86.63
- QULIPTA (Drug) $84.47
- BYDUREON (Drug) $81.03
- FREESTYLE LIBRE 2 (Device) $80.00
- Victoza (Drug) $79.50
- LifeVest (Device) $76.54
- Wegovy (Drug) $73.25
- XIFAXAN (Drug) $72.48
- Baxdela (Drug) $68.98
- LONHALA MAGNAIR (Drug) $68.74
- LOKELMA (Drug) $65.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Beckley
Dr. Saad Zafar, D.o, D.O
Internal Medicine — Payments: $8,608
Internal Medicine $8,608
Dr. Wadih Kabbara, Md, MD
Internal Medicine — Payments: $6,045
Internal Medicine $6,045
Dr. Mustafa Rahim, M.d, M.D
Internal Medicine — Payments: $5,507
Internal Medicine $5,507
Dr. Hassan Jafary, Md, MD
Internal Medicine — Payments: $3,463
Internal Medicine $3,463
Dr. Joseph Morrello, D.o, D.O
Internal Medicine — Payments: $3,183
Internal Medicine $3,183
Dr. Surayia Hasan, Md, MD
Internal Medicine — Payments: $3,036
Internal Medicine $3,036